팔로우
Cristina Maccalli
Cristina Maccalli
Sidra Medicine
sidra.org의 이메일 확인됨
제목
인용
인용
연도
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma PatientsImmune Properties of GBM-Derived Stem Cells
T Di Tomaso, S Mazzoleni, E Wang, G Sovena, D Clavenna, A Franzin, ...
Clinical Cancer Research 16 (3), 800-813, 2010
3182010
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
A Anichini, C Maccalli, R Mortarini, S Salvi, A Mazzocchi, P Squarcina, ...
The Journal of experimental medicine 177 (4), 989-998, 1993
2541993
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ...
Journal for immunotherapy of cancer 4 (1), 1-25, 2016
2192016
Human NK cells selective targeting of colon cancer–initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules
R Tallerico, M Todaro, S Di Franco, C Maccalli, C Garofalo, R Sottile, ...
The Journal of Immunology 190 (5), 2381-2390, 2013
2082013
Immunology and immunotherapy of colorectal cancer
P Dalerba, C Maccalli, C Casati, C Castelli, G Parmiani
Critical reviews in oncology/hematology 46 (1), 33-57, 2003
1782003
Defining the critical hurdles in cancer immunotherapy
BA Fox, DJ Schendel, LH Butterfield, S Aamdal, JP Allison, PA Ascierto, ...
Journal of translational medicine 9 (1), 1-15, 2011
1722011
Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2. 1-restricted immune repertoire to melanoma.
A Anichini, R Mortarini, C Maccalli, P Squarcina, K Fleischhauer, ...
The Journal of Immunology 156 (1), 208-217, 1996
1701996
Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan …
M Sensi, C Traversari, M Radrizzani, S Salvi, C Maccalli, R Mortarini, ...
Proceedings of the National Academy of Sciences 92 (12), 5674-5678, 1995
1351995
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
AM Di Giacomo, PA Ascierto, P Queirolo, L Pilla, R Ridolfi, M Santinami, ...
Annals of Oncology 26 (4), 798-803, 2015
1242015
Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines.
MP Colombo, C Maccalli, S Mattei, C Melani, M Radrizzani, G Parmiani
Melanoma research 2 (3), 181-189, 1992
1211992
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
W Hendrickx, I Simeone, S Anjum, Y Mokrab, F Bertucci, P Finetti, ...
Oncoimmunology 6 (2), e1253654, 2017
1162017
Immunology of cancer stem cells in solid tumours. A review
C Maccalli, A Volontè, C Cimminiello, G Parmiani
European journal of cancer 50 (3), 649-655, 2014
1142014
Recommendations from the iSBTc-SITC/FDA/NCI workshop on immunotherapy biomarkers
LH Butterfield, AK Palucka, CM Britten, MV Dhodapkar, L Håkansson, ...
Clinical Cancer Research 17 (10), 3064-3076, 2011
1142011
Immunogenomic classification of colorectal cancer and therapeutic implications
J Roelands, PJK Kuppen, L Vermeulen, C Maccalli, J Decock, E Wang, ...
International journal of molecular sciences 18 (10), 2229, 2017
1032017
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain …
M Sensi, S Salvi, C Castelli, C Maccalli, A Mazzocchi, R Mortarini, ...
The Journal of experimental medicine 178 (4), 1231-1246, 1993
1011993
Cancer-initiating cells from colorectal cancer patients escape from T cell–mediated immunosurveillance in vitro through membrane-bound IL-4
A Volonté, T Di Tomaso, M Spinelli, M Todaro, F Sanvito, L Albarello, ...
The Journal of Immunology 192 (1), 523-532, 2014
1002014
Immunomodulating and immunoresistance properties of cancer-initiating cells: implications for the clinical success of immunotherapy
C Maccalli, G Parmiani, S Ferrone
Immunological investigations 46 (3), 221-238, 2017
812017
NKG2D engagement of colorectal cancer‐specific T cells strengthens TCR‐mediated antigen stimulation and elicits TCR independent anti‐tumor activity
C Maccalli, D Pende, C Castelli, MC Mingari, PF Robbins, G Parmiani
European journal of immunology 33 (7), 2033-2043, 2003
772003
Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.
M Sensi, C Farina, C Maccalli, R Lupetti, G Nicolini, A Anichini, ...
The Journal of clinical investigation 99 (4), 710-717, 1997
741997
TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors
C Maccalli, S Scaramuzza, G Parmiani
Cancer immunology, immunotherapy 58 (5), 801-808, 2009
692009
현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.
학술자료 1–20